Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin for Primary Hypercholesterolaemia
NCT00396240Phase 4Withdrawn
- Sponsor
- AstraZeneca
- Start
- Feb 2002
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of rosuvastatin in primary hypercholesterolaemia, sponsored by AstraZeneca. Planned start Feb 2002; status: withdrawn.
02
Drugs
rosuvastatin
03
Conditions
primary hypercholesterolaemia
Beyond the preview
Go deeper on NCT00396240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00396240.